Journal article

Publication year: 2010

Pages: 87-92

Journal: Zeitschrift für Rheumatologie

Volume number: 69

Issue number: 1

ISSN: 0340-1855

eISSN: 1435-1250

DOI Link: https://doi.org/10.1007/s00393-009-0467-x

Publisher: Springer

Abstract: 
Not only in rheumatology is systemic sclerosis (SSc) considered one of the rarest diseases with a prevalence of approximately 5-20/100.000. Thus, in order to obtain reliable data on which to base therapy recommendations, the European network EUSTAR (EULAR Scleroderma Trials and Research) was set up alongside the German Network for Systemic Sclerosis (DNSS). As a result, initial recommendations for the treatment of SSc were recently published. In a Delphi approach, the selection of a preliminary set of research questions was followed by an analysis of clinical research evidence from over 5000 publications up to the end of 2006. These data were matched with current expert opinion and clinical experience, and in total 14 recommendations for the treatment of SSc were formulated: 3 on acral ulcers, 3 on gastrointestinal involvement, 4 on pulmonary arterial hypertension, 2 on renal crisis, 1 on skin involvement and 1 on interstitial lung disease.

Harvard Citation style: Schmeiser, T. and Mueller-Ladner, U. (2010) EULAR recommendations for the treatment of systemic sclerosis, Zeitschrift für Rheumatologie, 69(1), pp. 87-92. https://doi.org/10.1007/s00393-009-0467-x

APA Citation style: Schmeiser, T., & Mueller-Ladner, U. (2010). EULAR recommendations for the treatment of systemic sclerosis. Zeitschrift für Rheumatologie. 69(1), 87-92. https://doi.org/10.1007/s00393-009-0467-x